Onychomycosis treatment involves medical interventions and strategies employed to address and cure onychomycosis, a fungal infection that impacts both fingernails and toenails. The management of onychomycosis typically comprises a combination of topical and oral antifungal medications, along with preventive measures aimed at reducing the risk of recurrence.
The primary forms of onychomycosis include distal sublingual onychomycosis, white superficial onychomycosis, proximal sublingual onychomycosis, candida onychomycosis, and others. Distal sublingual onychomycosis, for instance, is a fungal nail infection that affects the underside of the nail tip, often caused by dermatophyte fungi. Treatments encompass a variety of approaches, including medications, laser therapy, and photodynamic therapy, catering to different age groups, including individuals aged 0 to 18 years, 18 to 39 years, 40 to 64 years, and those aged 65 years and above. Multiple distribution channels are involved, including hospital pharmacies, retail pharmacies, and others.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.
The onychomycosis treatment market research report is one of a series of new reports from The Business Research Company that provides onychomycosis treatment market statistics, including onychomycosis treatment industry global market size, regional shares, competitors with a onychomycosis treatment market share, detailed onychomycosis treatment market segments, market trends and opportunities and any further data you may need to thrive in the onychomycosis treatment industry. This onychomycosis treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The onychomycosis treatment market size has grown strongly in recent years. It will grow from $3.65 billion in 2024 to $3.91 billion in 2025 at a compound annual growth rate (CAGR) of 7.1%. The growth in the historic period can be attributed to increasing fungal infections, aging population, public awareness, rising prevalence of onychomycosis, rising disposable incomes.
The onychomycosis treatment market size is expected to see strong growth in the next few years. It will grow to $5.1 billion in 2029 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period can be attributed to aging population, telemedicine expansion, combination therapies, increasing access to healthcare, changing lifestyles and environmental factors, increasing prevalence of diabetes. Major trends in the forecast period include dermatological advancements, drug delivery innovations, personalized treatment plans, topical treatment advances, digital health solutions, laser therapy.
The forecast of 6.9% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. patients by driving up the cost of topical amorolfine and oral terbinafine sourced from India and Spain, exacerbating out-of-pocket costs and reducing medication adherence for fungal nail infections. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The rising incidence of fungal infections is expected to drive the growth of the onychomycosis treatment market in the coming years. Fungal infections are microbial diseases caused by various fungi, impacting different parts of the body and leading to specific conditions. Onychomycosis, or fungal nail infection, is commonly treated with oral antifungal medications or topical antifungal solutions to eradicate the underlying fungal growth and promote healthy nail regrowth. For example, in September 2023, the UK Health Security Agency, a government body in the UK, reported that there were 2,265 recorded cases of bloodstream infections (BSI) caused by yeast in England in 2022, as tracked by the SGSS. The incidence rate of BSI due to yeast increased slightly to 4.0 per 100,000 people, up from 3.8 per 100,000 in 2021. The three most frequently identified yeast species in blood samples were Candida albicans (40%), Nakaseomyces glabratus (previously known as Candida glabrata, 29%), and Candida parapsilosis (13%). Thus, the rising number of fungal infections is contributing to the growth of the onychomycosis treatment market.
The rising prevalence of diabetes is poised to drive the growth of the onychomycosis treatment market in the foreseeable future. Diabetes is a chronic medical condition characterized by elevated levels of blood glucose (blood sugar), increasing the likelihood of developing onychomycosis, elevating the risk of infection, and delaying the healing process. Topical and laser therapies play a crucial role in preventing complications and enhancing foot health, ultimately reducing the risk of subsequent infections. For example, in March 2021, a report from the LSU AgCenter, a Louisiana-based agricultural research center, indicated that in 2021, the United States had over 34.2 million individuals living with diabetes, and it is projected that the global population affected by diabetes will surge to 578 million by the year 2030. As a result, the growing prevalence of diabetes is a key driver behind the expansion of the onychomycosis treatment market.
Prominent companies operating in the onychomycosis treatment market are placing a strong emphasis on the development of novel products, like MOB-015, and obtaining approvals from regulatory agencies as part of their strategy to secure a competitive edge within the market. For instance, Moberg Pharma AB, a pharmaceutical company based in Sweden, which successfully obtained approval for MOB-015 from the European Union to treat mild to moderate fungal nail infections in adults. This EU approval marks a significant milestone as the first global marketing authorization for this innovative onychomycosis medication. The approval is underpinned by two Phase 3 trials supporting MOB-015, which demonstrated enhanced mycological cure rates (76% compared to up to 42% for comparators) and a substantially higher overall cure rate than the vehicle, all achieved without any occurrence of serious adverse effects. MOB-015, a topical terbinafine formulation, enables the delivery of effective terbinafine concentrations to the nail and nail bed without the associated systemic exposure risk associated with oral terbinafine treatments.
In August 2023, Karo Healthcare AB, a Swedish consumer healthcare company, completed the acquisition of Lamisil from Haleon PLC for an approximate sum of $297.86 million. This strategic move to acquire Lamisil significantly enriches Karo Healthcare's portfolio of over-the-counter (OTC) products and extends its offerings within the field of foot health. Furthermore, this transaction serves to broaden Karo's global footprint and augment its market presence in the realm of Foot Health. Lamisil, a well-known oral antifungal medication primarily utilized for the treatment of onychomycosis, was previously held by Haleon PLC, a UK-based consumer healthcare enterprise.
Major companies operating in the onychomycosis treatment market are Johnson & Johnson Services Inc., Bristol-Myers Squibb Company, Viatris Inc., Teva Pharmaceutical Industries Ltd., Hetero Drugs Ltd., Sun Pharmaceutical Industries Limited, Cadila Pharmaceuticals Ltd., Dr. Reddys Laboratories Ltd., Intas Pharmaceuticals Limited, Cipla Limited, Lupin Limited, Glenmark Pharmaceuticals Ltd., Aurobindo Pharma Limited, Alkem Laboratories Limited, Jubilant Life Sciences Ltd., Torrent Pharmaceuticals Ltd., Mankind Pharma Ltd., Biocon Limited, Emcure Pharmaceuticals Limited, Alembic Pharmaceuticals Ltd., Laurus Labs Limited, Strides Pharma Science Limited, Aarti Drugs Ltd., NATCO Pharma Ltd., Unichem Laboratories Ltd., Indoco Remedies Ltd., Apex Laboratories Pvt. Ltd., Wockhardt Ltd., Nuray Chemicals Private Limited.
North America was the largest region in the onychomycosis treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in onychomycosis treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the onychomycosis treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The onychomycosis treatment market consists of revenues earned by entities by providing combination therapy, nail debridement and Carbon dioxide ablative laser treatment. The market value includes the value of related goods sold by the service provider or included within the service offering. The onychomycosis treatment market also includes sales of griseofulvin, terbinafine, itraconazole, ketoconazole and more. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Onychomycosis Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on onychomycosis treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for onychomycosis treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The onychomycosis treatment market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Type: Distal Sublingual Onychomycosis; White Superficial Onychomycosis; Proximal Sublingual Onychomycosis; Candida Onychomycosis; Other Types
- 2) By Treatment Type: Drugs; Laser Therapy; Photodynamic Therapy
- 3) By Age Group: 0 To 18 Years; 18 To 39 Years; 40 To 64 Years; 65 Years And Above
- 4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Other Distribution Channels
- Companies Mentioned: Johnson & Johnson Services Inc.; Bristol-Myers Squibb Company; Viatris Inc.; Teva Pharmaceutical Industries Ltd.; Hetero Drugs Ltd.; Sun Pharmaceutical Industries Limited; Cadila Pharmaceuticals Ltd.; Dr. Reddys Laboratories Ltd.; Intas Pharmaceuticals Limited; Cipla Limited; Lupin Limited; Glenmark Pharmaceuticals Ltd.; Aurobindo Pharma Limited; Alkem Laboratories Limited; Jubilant Life Sciences Ltd.; Torrent Pharmaceuticals Ltd.; Mankind Pharma Ltd.; Biocon Limited; Emcure Pharmaceuticals Limited; Alembic Pharmaceuticals Ltd.; Laurus Labs Limited; Strides Pharma Science Limited; Aarti Drugs Ltd.; NATCO Pharma Ltd.; Unichem Laboratories Ltd.; Indoco Remedies Ltd.; Apex Laboratories Pvt. Ltd.; Wockhardt Ltd.; Nuray Chemicals Private Limited.
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time Series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Onychomycosis Treatment Market Characteristics
3. Onychomycosis Treatment Market Trends And Strategies
4. Onychomycosis Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
- 4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Onychomycosis Treatment Growth Analysis And Strategic Analysis Framework
- 5.1. Global Onychomycosis Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Onychomycosis Treatment Market Growth Rate Analysis
- 5.4. Global Onychomycosis Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Onychomycosis Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Onychomycosis Treatment Total Addressable Market (TAM)
6. Onychomycosis Treatment Market Segmentation
- 6.1. Global Onychomycosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Distal Sublingual Onychomycosis
- White Superficial Onychomycosis
- Proximal Sublingual Onychomycosis
- Candida Onychomycosis
- Other Types
- 6.2. Global Onychomycosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Drugs
- Laser Therapy
- Photodynamic Therapy
- 6.3. Global Onychomycosis Treatment Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 0 To 18 Years
- 18 To 39 Years
- 40 To 64 Years
- 65 Years And Above
- 6.4. Global Onychomycosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospital Pharmacies
- Retail Pharmacies
- Other Distribution Channels
7. Onychomycosis Treatment Market Regional And Country Analysis
- 7.1. Global Onychomycosis Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Onychomycosis Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Onychomycosis Treatment Market
- 8.1. Asia-Pacific Onychomycosis Treatment Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Onychomycosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Onychomycosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Onychomycosis Treatment Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Onychomycosis Treatment Market
- 9.1. China Onychomycosis Treatment Market Overview
- 9.2. China Onychomycosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Onychomycosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Onychomycosis Treatment Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Onychomycosis Treatment Market
- 10.1. India Onychomycosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Onychomycosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Onychomycosis Treatment Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Onychomycosis Treatment Market
- 11.1. Japan Onychomycosis Treatment Market Overview
- 11.2. Japan Onychomycosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Onychomycosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Onychomycosis Treatment Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Onychomycosis Treatment Market
- 12.1. Australia Onychomycosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Onychomycosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Onychomycosis Treatment Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Onychomycosis Treatment Market
- 13.1. Indonesia Onychomycosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Onychomycosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Onychomycosis Treatment Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Onychomycosis Treatment Market
- 14.1. South Korea Onychomycosis Treatment Market Overview
- 14.2. South Korea Onychomycosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Onychomycosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Onychomycosis Treatment Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Onychomycosis Treatment Market
- 15.1. Western Europe Onychomycosis Treatment Market Overview
- 15.2. Western Europe Onychomycosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Onychomycosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Onychomycosis Treatment Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Onychomycosis Treatment Market
- 16.1. UK Onychomycosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Onychomycosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Onychomycosis Treatment Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Onychomycosis Treatment Market
- 17.1. Germany Onychomycosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Onychomycosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Onychomycosis Treatment Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Onychomycosis Treatment Market
- 18.1. France Onychomycosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Onychomycosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Onychomycosis Treatment Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Onychomycosis Treatment Market
- 19.1. Italy Onychomycosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Onychomycosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Onychomycosis Treatment Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Onychomycosis Treatment Market
- 20.1. Spain Onychomycosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Onychomycosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Onychomycosis Treatment Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Onychomycosis Treatment Market
- 21.1. Eastern Europe Onychomycosis Treatment Market Overview
- 21.2. Eastern Europe Onychomycosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Onychomycosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Onychomycosis Treatment Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Onychomycosis Treatment Market
- 22.1. Russia Onychomycosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Onychomycosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Onychomycosis Treatment Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Onychomycosis Treatment Market
- 23.1. North America Onychomycosis Treatment Market Overview
- 23.2. North America Onychomycosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Onychomycosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Onychomycosis Treatment Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Onychomycosis Treatment Market
- 24.1. USA Onychomycosis Treatment Market Overview
- 24.2. USA Onychomycosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Onychomycosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Onychomycosis Treatment Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Onychomycosis Treatment Market
- 25.1. Canada Onychomycosis Treatment Market Overview
- 25.2. Canada Onychomycosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Onychomycosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Onychomycosis Treatment Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Onychomycosis Treatment Market
- 26.1. South America Onychomycosis Treatment Market Overview
- 26.2. South America Onychomycosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Onychomycosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Onychomycosis Treatment Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Onychomycosis Treatment Market
- 27.1. Brazil Onychomycosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Onychomycosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Onychomycosis Treatment Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Onychomycosis Treatment Market
- 28.1. Middle East Onychomycosis Treatment Market Overview
- 28.2. Middle East Onychomycosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Onychomycosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Onychomycosis Treatment Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Onychomycosis Treatment Market
- 29.1. Africa Onychomycosis Treatment Market Overview
- 29.2. Africa Onychomycosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Onychomycosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Onychomycosis Treatment Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Onychomycosis Treatment Market Competitive Landscape And Company Profiles
- 30.1. Onychomycosis Treatment Market Competitive Landscape
- 30.2. Onychomycosis Treatment Market Company Profiles
- 30.2.1. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Viatris Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Hetero Drugs Ltd. Overview, Products and Services, Strategy and Financial Analysis
31. Onychomycosis Treatment Market Other Major And Innovative Companies
- 31.1. Sun Pharmaceutical Industries Limited
- 31.2. Cadila Pharmaceuticals Ltd.
- 31.3. Dr. Reddys Laboratories Ltd.
- 31.4. Intas Pharmaceuticals Limited
- 31.5. Cipla Limited
- 31.6. Lupin Limited
- 31.7. Glenmark Pharmaceuticals Ltd.
- 31.8. Aurobindo Pharma Limited
- 31.9. Alkem Laboratories Limited
- 31.10. Jubilant Life Sciences Ltd.
- 31.11. Torrent Pharmaceuticals Ltd.
- 31.12. Mankind Pharma Ltd.
- 31.13. Biocon Limited
- 31.14. Emcure Pharmaceuticals Limited
- 31.15. Alembic Pharmaceuticals Ltd.
32. Global Onychomycosis Treatment Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Onychomycosis Treatment Market
34. Recent Developments In The Onychomycosis Treatment Market
35. Onychomycosis Treatment Market High Potential Countries, Segments and Strategies
- 35.1 Onychomycosis Treatment Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Onychomycosis Treatment Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Onychomycosis Treatment Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
